Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis (WBI-1001-101)

This study has been completed.
Information provided by:
Welichem Biotech Inc. Identifier:
First received: January 26, 2009
Last updated: January 27, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)